great result .. surprised it didn't jump a bit more on cash potential to feed further M&A ... wonder what will be next. have done a lot of research here and VB is running his true and tried formula.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%